Skip to content
AnalystLens

CACI International Quarterly Report for Q2 Ended Dec 31, 2023

Filing Date
Filed January 25, 2024
Period End
December 31, 2023
Security
CACI
In the record · 2016–202610-K1110-Q338-K122

CACI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Feb ’16Feb ’16
  2. Material agreement8-K · Dec ’19Dec ’19
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Jun ’26Jun ’26

Summary

Summary of the 10-Q filed January 25, 2024. Cited figures are marked; the original filing is the authoritative source.

CACI International Inc (CACI) reported results for the three and six months ended December 31, 2023 in this Form 10-Q.

Revenues were $1,833,934 thousanda for the quarter, up from $1,649,416 thousand a year earlier, and $3,684,081 thousand for the six months, up from $3,255,175 thousand. Income from operations was $133,305 thousand for the quarter versus $130,867 thousand, while net income declined to $83,870 thousand from $87,101 thousand, and diluted earnings per share were $3.74 versus $3.68 in the prior-year quarter. For the six months, net income was $169,917 thousand versus $176,226 thousand, and diluted EPS was $7.50 versus $7.44.

The filing attributes revenue growth primarily to new contract awards and growth on existing programs, and notes that interest expense rose on higher interest rates and higher debt balances. Total backlog was $26.9 billionb at December 31, 2023, compared with $26.5 billion a year earlier, an increase of 1.5% as stated in the filing. Net cash provided by operating activities was $141,852 thousand for the six months, down from $207,090 thousand, driven by a $76.8 million decrease in cash received from the company's receivables sale program and the timing of vendor payments, partly offset by lower income tax payments.

The company repurchased $155,765 thousandc of common stock in the six months and had $617.5 million drawn on its revolving facility at period end. Total debt principal was $1,781,250 thousand.

The filing also discloses a subsequent event: on January 11, 2024, the company agreed to acquire a business for approximately $67.0 milliond, with closing expected in the third quarter of fiscal 2024. The company continues to describe its legal proceedings, including the Al Shimari and Abbass matters, which it says it is vigorously defending, and the filing reports that the Al Shimari case is set for a jury trial on April 15, 2024.

Key Highlights

  1. Revenue of $1,833,934 thousand for the quarter, up from $1,649,416 thousand; six-month revenue of $3,684,081 thousand, up from $3,255,175 thousand.
  2. Net income of $83,870 thousand for the quarter, down from $87,101 thousand; diluted EPS of $3.74 versus $3.68 a year earlier.
  3. Total backlog of $26.9 billion at December 31, 2023, versus $26.5 billion a year earlier; funded backlog of $3.7 billion.
  4. Net cash provided by operating activities of $141,852 thousand for the six months, down from $207,090 thousand, mainly due to lower receivables sale proceeds and timing of vendor payments.
  5. Repurchased $155,765 thousand of common stock in the six months; $337.3 million remained under the 2023 Repurchase Program at period end.
  6. Long-term debt principal of $1,781,250 thousand, including $617.5 million drawn on the revolving facility, with the company stating it was in compliance with all financial covenants.
  7. Agreed on January 11, 2024 to acquire a business for approximately $67.0 million, expected to close in the third quarter of fiscal 2024.

Financial Statements

Q2 FY2024 against Q2 FY2023

Line itemQ2 FY2024Q2 FY2023Change
Revenue$1.83B$1.65B+11.2%
SG&A Expenses$409.36M$388.30M+5.4%
Operating Expenses$1.70B$1.52B+12.0%
Operating Income$133.31M$130.87M+1.9%
Interest Expense$27.52M$19.94M+38.0%
Net Income$83.87M$87.10M−3.7%
EPS (Basic)$3.76$3.71+1.3%
EPS (Diluted)$3.74$3.68+1.6%
Shares Outstanding (Basic)22.28M23.51M−5.2%
Shares Outstanding (Diluted)22.41M23.68M−5.4%

Frequently Asked Questions

  1. How did CACI's revenue and profitability change in the quarter ended December 31, 2023?

    Revenues rose to $1,833,934 thousand from $1,649,416 thousand, which the filing attributes primarily to new contract awards and growth on existing programs. Net income fell to $83,870 thousand from $87,101 thousand, and diluted EPS was $3.74 compared with $3.68. Direct costs grew faster than revenue, and the filing reports direct costs at 68.4% of revenue versus 66.3% a year earlier.

  2. What is the size of CACI's backlog and how has it changed?

    Total backlog was $26.9 billion as of December 31, 2023, compared with $26.5 billion a year earlier, an increase of 1.5% as stated in the filing. Funded backlog was $3.7 billion. The filing notes that backlog is subject to change from new awards, modifications, deobligations, and early terminations.

  3. Why did operating cash flow decline in the first half of fiscal 2024?

    Net cash provided by operating activities decreased by $65.2 million to $141,852 thousand for the six months. The filing attributes this to a $76.8 million decrease in cash received from the company's receivables sale program (MARPA) and $75.0 million in net unfavorable changes in operating assets and liabilities, driven by higher revenue volume and the timing of vendor payments. These were partly offset by a $40.0 million reduction in income tax payments and a $46.6 million reduction in CARES Act payroll tax payments.

  4. What capital allocation actions did CACI take, and what remains available?

    The company repurchased $155,765 thousand of common stock in the six months, including an accelerated share repurchase and open-market purchases. Total remaining authorization under the 2023 Repurchase Program was $337.3 million as of December 31, 2023. The company also made acquisitions of businesses totaling $10,869 thousand in cash, net of cash acquired, during the six months.

  5. What are the main pending legal matters and what does the company say about them?

    The filing describes the Al Shimari v. L-3 Services case, in which CACI International Inc and CACI Premier Technology, Inc. are named defendants, and the Abbass case, which is stayed pending the outcome of the Al Shimari appeal. The District Court set a jury trial for Al Shimari on April 15, 2024. The company states it is vigorously defending both matters and believes the lawsuits are completely without merit.